Gene expression profiling from high-fat medium (HFM)-treated and growth medium (GM)-treated Sk-hep1 cells
Ontology highlight
ABSTRACT: Non-alcoholic fatty liver disease (NAFLD) is a major problem in obese peoples and caused by unbalanced uptake of fatty acid. Novel drug identification is necessary to develop effective therapies. We combine LOPAC® and High-Content system to identify compounds significantly reducing intracellular lipid droplets after high fat medium (HFM) treatment. Among 1280 compounds, 5 show efficacy in lipid droplet reduction. To construct the underlying regulatory network, whole-genome transcriptomic, pathway, and connectivity map analysis are performed.
ORGANISM(S): Homo sapiens
PROVIDER: GSE109836 | GEO | 2018/01/31
REPOSITORIES: GEO
ACCESS DATA